These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 30127421)

  • 21. Non-vaccine Pneumococcal Serotypes Among Children with Invasive Pneumococcal Disease.
    John J; Varghese R; Lionell J; Neeravi A; Veeraraghavan B
    Indian Pediatr; 2018 Oct; 55(10):874-876. PubMed ID: 30426954
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serotypes and antimicrobial resistance of streptococcus pneumoniae in Thailand 2002-2004.
    Levine S; Dejsirilert S; Sangsuk L; Chantra S; Feikin DR; Dowell SF; Olsen SJ
    Pediatr Infect Dis J; 2006 Feb; 25(2):176-8. PubMed ID: 16462300
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The importance of pharmacodynamic properties in treatment of penicillin resistant Streptococcus pneumoniae.
    Knudsen JD
    Dan Med Bull; 2000 Nov; 47(5):313-27. PubMed ID: 11155659
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Modular Architecture and Unique Teichoic Acid Recognition Features of Choline-Binding Protein L (CbpL) Contributing to Pneumococcal Pathogenesis.
    Gutiérrez-Fernández J; Saleh M; Alcorlo M; Gómez-Mejía A; Pantoja-Uceda D; Treviño MA; Voß F; Abdullah MR; Galán-Bartual S; Seinen J; Sánchez-Murcia PA; Gago F; Bruix M; Hammerschmidt S; Hermoso JA
    Sci Rep; 2016 Dec; 6():38094. PubMed ID: 27917891
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Quinolones with enhanced bactericidal activity induce autolysis in Streptococcus pneumoniae.
    Okumura R; Hoshino K; Otani T; Yamamoto T
    Chemotherapy; 2009; 55(4):262-9. PubMed ID: 19468224
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In Vivo Pharmacodynamic Target Investigation of Two Bacterial Topoisomerase Inhibitors, ACT-387042 and ACT-292706, in the Neutropenic Murine Thigh Model against Streptococcus pneumoniae and Staphylococcus aureus.
    Lepak AJ; Seiler P; Surivet JP; Ritz D; Kohl C; Andes DR
    Antimicrob Agents Chemother; 2016 Jun; 60(6):3626-32. PubMed ID: 27044547
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Changes in antimicrobial resistance, serotypes and genotypes in Streptococcus pneumoniae over a 30-year period.
    Liñares J; Ardanuy C; Pallares R; Fenoll A
    Clin Microbiol Infect; 2010 May; 16(5):402-10. PubMed ID: 20132251
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy of 13-valent pneumococcal conjugate vaccine (PCV13) versus that of 7-valent PCV (PCV7) against nasopharyngeal colonization of antibiotic-nonsusceptible Streptococcus pneumoniae.
    Dagan R; Juergens C; Trammel J; Patterson S; Greenberg D; Givon-Lavi N; Porat N; Gurtman A; Gruber WC; Scott DA
    J Infect Dis; 2015 Apr; 211(7):1144-53. PubMed ID: 25355940
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy of Solithromycin (CEM-101) for Experimental Otitis Media Caused by Nontypeable Haemophilus influenzae and Streptococcus pneumoniae.
    Figueira M; Fernandes P; Pelton SI
    Antimicrob Agents Chemother; 2016 Sep; 60(9):5533-8. PubMed ID: 27401563
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Incorporation of choline into Streptococcus pneumoniae cell wall antigens: evidence for choline kinase activity.
    Whiting GC; Gillespie SH
    FEMS Microbiol Lett; 1996 May; 138(2-3):141-5. PubMed ID: 9026440
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Multivalent choline dendrimers as potent inhibitors of pneumococcal cell-wall hydrolysis.
    Hernández-Rocamora VM; Maestro B; de Waal B; Morales M; García P; Meijer EW; Merkx M; Sanz JM
    Angew Chem Int Ed Engl; 2009; 48(5):948-51. PubMed ID: 19115336
    [No Abstract]   [Full Text] [Related]  

  • 32. Serotype distribution and antimicrobial susceptibilities of nasopharyngeal isolates of Streptococcus pneumoniae from healthy children in the 13-valent pneumococcal conjugate vaccine era.
    Zuccotti G; Mameli C; Daprai L; Garlaschi ML; Dilillo D; Bedogni G; Faccini M; Gramegna M; Torresani E; ; Ballerini E; Benincaso A; Bonvissuto M; Bricalli D; Brioschi M; Calloni CS; Camiletti MI; Colella G; De Angelis L; Decarlis S; Di Nello F; Dozzi M; Galli E; Gandini V; Giuliani MG; Laviola F; Loda B; Macedoni M; Mazzucchi E; Metta MG; Moscatiello A; Nannini P; Petruzzi M; Picicco D; Picciotti M; Pisanelli S; Porta N; Ramponi G; Redaelli F; Rubini R; Sala N; Saitta V; Scelza G; Tiso RM; Tomasetto M; Torcoletti M; Travaini M; Valentini M; Vessia C
    Vaccine; 2014 Jan; 32(5):527-34. PubMed ID: 24342249
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Nasopharyngeal colonization of Streptococcus pneumoniae in healthy children: percentage of carriers, serotypes distribution and antibiotic resistance].
    Schettini F; Miragliotta G; Carucci A; Mosca A; Del Vecchio GC; Laforgia N; De Mattia D
    Minerva Pediatr; 2003 Oct; 55(5):439-45. PubMed ID: 14608266
    [TBL] [Abstract][Full Text] [Related]  

  • 34. AUC(0-t)/MIC is a continuous index of fluoroquinolone exposure and predictive of antibacterial response for Streptococcus pneumoniae in an in vitro infection model.
    Zelenitsky SA; Ariano RE; Iacovides H; Sun S; Harding GK
    J Antimicrob Chemother; 2003 Apr; 51(4):905-11. PubMed ID: 12654762
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antimicrobial activity of DW286 against Streptococcus pneumoniae.
    Park HS; Jung SJ; Choi DR; Kwak JH
    Int J Antimicrob Agents; 2010 Sep; 36(3):230-3. PubMed ID: 20627463
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bactericidal activities of parenteral antibiotics and genotype of penicillin-binding protein in Streptococcus pneumoniae and Haemophilus influenzae isolated from children's blood.
    Sakata H
    J Infect Chemother; 2006 Oct; 12(5):338-42. PubMed ID: 17109098
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serotype distribution and susceptibility to penicillin and erythromycin among noninvasive or colonization isolates of Streptococcus pneumoniae in northern Japan: a cross-sectional study in the pre-PCV7 routine immunization period.
    Kawaguchiya M; Urushibara N; Ghosh S; Kuwahara O; Morimoto S; Ito M; Kudo K; Kobayashi N
    Microb Drug Resist; 2014 Oct; 20(5):456-65. PubMed ID: 24766085
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of the 13-valent pneumococcal conjugate vaccine on chronic sinusitis associated with Streptococcus pneumoniae in children.
    Olarte L; Hulten KG; Lamberth L; Mason EO; Kaplan SL
    Pediatr Infect Dis J; 2014 Oct; 33(10):1033-6. PubMed ID: 24776520
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Changes in Streptococcus pneumoniae serotype distribution in invasive disease and nasopharyngeal carriage after the heptavalent pneumococcal conjugate vaccine introduction in Bogotá, Colombia.
    Parra EL; De La Hoz F; Díaz PL; Sanabria O; Realpe ME; Moreno J
    Vaccine; 2013 Aug; 31(37):4033-8. PubMed ID: 23680440
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Detection of pneumolysin and autolysin genes among antibiotic resistant Streptococcus pneumoniae in invasive infections.
    Sourav S; Patricia A; Sharma S; Kanungo R; Jayachandran S; Prashanth K
    Indian J Med Microbiol; 2010; 28(1):34-9. PubMed ID: 20061761
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.